In perfect harmony

Covering the pharma and biopharma manufacturing supply chain from formulation to distribution, European Pharmaceutical Manufacturer keeps readers informed on the latest news, opinions and developments in an innovative and technologically advanced sector.

The available market for biosimilar manufacturers seeking to compete with original reference biologics coming off patent, between late 2018 and 2023 in Europe and the US, is considerable. However, Owen Mumford Pharmaceutical Services says, even where clinicians encourage the use of biosimilars for the patient, there remains some key considerations to overcome. This article goes into depth about these key issues and what you need to know.

Article found on page 27 of the link below.